Pharmaceutical Contract Manufacturing and Research Services Market Market - Top Companies and Manufacturers

Companies Dominating the Pharmaceutical Contract Manufacturing and Research Services Landscape:

There are many national and international competitors in the pharmaceutical contract manufacturing and research services market. The major competitors are implementing a variety of growth tactics, including alliances, partnerships, joint ventures, product launches, geographic expansions, mergers, and acquisitions, to increase their market share. Boehringer Ingelheim Biopharmaceuticals GmbH, AbbVie, Baxter BioPharma, Dalton Pharma Services, and Thermo Fisher Scientific (PPD, Inc.) are some of the major companies in the market.

To bolster their position in the market, market participants are concentrating on partnerships, acquisitions, agreements, and other tactics. For example, Boehringer Ingelheim and Enara Bio signed a planned collaboration and licensing deal in January 2021 for the latter's Dark Antigen discovery platform to be used in the research and development of innovative targeted cancer immunotherapies. Comparably, Charles River Laboratories International, Inc. declared in February 2021 that it had agreed to pay approximately USD 875 million to buy Cognate BioServices, Inc., a CDMO for cell and gene therapy.

Here are some leading players in the pharmaceutical contract manufacturing and research services market:

• Catalent, Inc.
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 
• Boehringer Ingelheim Biopharmaceuticals GmbH,
• AbbVie
• Recipharm AB
• Baxter BioPharma
• Dalton Pharma Services
• Thermo Fisher Scientific Inc.
• Piramal Pharma Solutions
• Jubilant Pharmova Limited
• Samsung Biologics